Verily Life Sciences, LLC Sustainability Profile
Verily Life Sciences, LLC, a prominent player in the life sciences industry, is headquartered in the United States. Founded in 2015, the company has rapidly established itself as a leader in health data analytics and innovative healthcare solutions. Verily focuses on various business areas, including disease prevention, management, and research, leveraging advanced technologies to improve patient outcomes. The company is renowned for its unique products and services, such as the Verily Study Watch and its extensive health data platform, which facilitate groundbreaking research and personalised healthcare. With a commitment to transforming healthcare through data-driven insights, Verily has achieved significant milestones, including partnerships with major healthcare organisations. Its strategic position in the market underscores its dedication to advancing health and wellness on a global scale.
DitchCarbon Score
How does Verily Life Sciences, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Verily Life Sciences, LLC's score of 88 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Verily Life Sciences, LLC, headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Alphabet Inc., which influences its climate commitments and emissions reporting. As part of its corporate family, Verily adheres to the sustainability initiatives and targets set by Alphabet Inc., including those related to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative. While specific reduction targets or achievements for Verily are not detailed, the overarching commitments from Alphabet Inc. suggest a focus on significant emissions reductions across its operations. This includes a commitment to achieving net-zero emissions and transitioning to 100% renewable energy, which may indirectly impact Verily's climate strategy. As of now, Verily Life Sciences has not publicly outlined its own specific climate pledges or reduction targets, but it is expected to align with the ambitious sustainability goals of its parent company, Alphabet Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 37,187,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 1,149,988,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 3 | 332,612,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Verily Life Sciences, LLC's Industry?
How Carbon Intensive is Verily Life Sciences, LLC's Location?
Verily Life Sciences, LLC's Scope 3 Categories Breakdown
Verily Life Sciences, LLC's Scope 3 emissions, which increased by 12% last year and increased significantly since 2012, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 79% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 30% of Scope 3 emissions.
Top Scope 3 Categories
Verily Life Sciences, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Verily Life Sciences, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
